Tonix Receives US Patent for Investigational Therapy TNX-102 SL to Treat Fibromyalgia
News
Tonix Pharmaceuticals has been granted a U.S. patent for its investigational therapy TNX-102 SL (cyclobenzaprine HCl sublingual tablets), designed to treat fibromyalgia, among other indications. Issued by the U.S. Patent ... Read more